Cambrian BioPharma

Cambrian Bio | Catalyzing breakthroughs

Cambrian BioPharma was founded in 2019, is headquartered in New York, United States, lists 11–50 employees, and has $243.0M in recorded funding across 4 rounds.

Headquarters
New York, New York
Employees
11–50
Founded
2019
Business Model
B2B Biotech
Total Funding
$243.0M
Last Round
$23.0M Venture RoundJan 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

Cambrian Bio is a clinical-stage drug development company building medicines to treat and ultimately prevent age-related chronic diseases. The company partners with scientists to advance a portfolio of longevity-focused pipeline programs, leveraging repeatable development models to extend human healthspan.

Summary

Cambrian BioPharma is a Biotech company based in New York, United States, founded in 2019. It lists 11–50 employees. It has raised $243.0M in total across 4 rounds, most recently a $23.0M Venture Round in Jan 2025. Investors include Apollo, Anthos Capital and Alumni Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJan 2025
$23.0M

Sign up to see all 4 events

Funding: Series B through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cambrian BioPharma on Indexed.vc
<a href="https://indexed.vc/companies/cambrian-biopharma"><img src="https://indexed.vc/api/badge/company/cambrian-biopharma" alt="Cambrian BioPharma on Indexed.vc" width="260" height="76" /></a>